A detailed history of Voya Investment Management LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 94,183 shares of SNDX stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,183
Previous 183,649 48.72%
Holding current value
$1.33 Million
Previous $3.77 Million 51.91%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.93 - $24.81 $1.6 Million - $2.22 Million
-89,466 Reduced 48.72%
94,183 $1.81 Million
Q2 2024

Dec 03, 2024

BUY
$18.82 - $23.79 $1.68 Million - $2.13 Million
89,466 Added 94.99%
183,649 $3.77 Million
Q2 2024

Aug 14, 2024

SELL
$18.82 - $23.79 $251,717 - $318,191
-13,375 Reduced 6.79%
183,649 $3.77 Million
Q1 2024

Dec 06, 2024

BUY
$19.71 - $24.57 $2.03 Million - $2.53 Million
102,841 Added 109.19%
197,024 $4.69 Million
Q1 2024

May 15, 2024

BUY
$19.71 - $24.57 $610,832 - $761,448
30,991 Added 18.67%
197,024 $4.69 Million
Q4 2023

Feb 14, 2024

BUY
$11.39 - $21.67 $1.33 Million - $2.54 Million
117,144 Added 239.61%
166,033 $3.59 Million
Q3 2023

Nov 14, 2023

SELL
$14.52 - $21.77 $1.19 Million - $1.78 Million
-81,729 Reduced 62.57%
48,889 $709,000
Q2 2023

Aug 14, 2023

BUY
$19.35 - $22.31 $414,515 - $477,924
21,422 Added 19.62%
130,618 $2.73 Million
Q1 2023

May 15, 2023

BUY
$20.66 - $28.98 $303,350 - $425,513
14,683 Added 15.54%
109,196 $2.31 Million
Q3 2022

Nov 14, 2022

BUY
$18.51 - $24.79 $1.39 Million - $1.87 Million
75,293 Added 391.74%
94,513 $2.27 Million
Q2 2022

Aug 15, 2022

BUY
$13.64 - $19.48 $19,464 - $27,797
1,427 Added 8.02%
19,220 $370,000
Q4 2021

Feb 14, 2022

SELL
$15.23 - $22.47 $60 - $89
-4 Reduced 0.02%
17,793 $389,000
Q3 2021

Nov 15, 2021

SELL
$13.87 - $19.8 $2.15 Million - $3.07 Million
-155,289 Reduced 89.72%
17,797 $340,000
Q2 2021

Aug 16, 2021

BUY
$13.42 - $25.18 $287,724 - $539,859
21,440 Added 14.14%
173,086 $2.97 Million
Q1 2021

May 17, 2021

SELL
$19.28 - $24.59 $432,970 - $552,217
-22,457 Reduced 12.9%
151,646 $3.39 Million
Q4 2020

Feb 16, 2021

BUY
$15.1 - $26.44 $2.63 Million - $4.6 Million
174,103 New
174,103 $3.87 Million
Q2 2020

Aug 14, 2020

SELL
$8.94 - $20.98 $103,060 - $241,857
-11,528 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.43 - $9.22 $62,597 - $106,288
11,528 New
11,528 $101,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $802M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.